During the past decade, Martini Ziekenhuis conducted 70 clinical trials. In the 10-year time frame, 70 clinical trials started and 13 clinical trials were completed, i.e. on average, 18.6% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 7 clinical trials were completed. i.e. 21.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Martini Ziekenhuis" #1 sponsor was "University Medical Center Groningen" with 11 trials, followed by "Maastricht University Medical Center" with 7 trials sponsored, "Boehringer Ingelheim" with 5 trials sponsored, "Martini Hospital Groningen" with 5 trials sponsored and "The Netherlands Cancer Institute" with 5 trials sponsored. Other sponsors include 71 different institutions and companies that sponsored additional 53 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Martini Ziekenhuis" #1 collaborator was "Maastricht University Medical Center" with 5 trials as a collaborator, "Martini Hospital Groningen" with 5 trials as a collaborator, "ZonMw: The Netherlands Organisation for Health Research and Development" with 5 trials as a collaborator, "Dutch Cancer Society" with 4 trials as a collaborator and "Roche Pharma AG" with 4 trials as a collaborator. Other collaborators include 165 different institutions and companies that were collaborators in the rest 143 trials.

According to Clinical.Site data, the most researched conditions in "Martini Ziekenhuis" are "Atrial Fibrillation" (11 trials), "Breast Cancer" (7 trials), "Heart Failure" (4 trials), "Burns" (3 trials) and "Cardiovascular Disease" (3 trials). Many other conditions were trialed in "Martini Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Martini Ziekenhuis" are "Drug" (61 trials), "Other" (16 trials), "Procedure" (13 trials), "Device" (10 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Pemetrexed" (4 trials), "Cisplatin" (3 trials), "Docetaxel" (3 trials) and "Fulvestrant" (3 trials). Other intervention names were less common.

The vast majority of trials in "Martini Ziekenhuis" are 92 trials for "All" genders, 15 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Martini Ziekenhuis". undefined are not yet recruiting, 26 are recruiting, 13 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 44 completed trials in Martini Ziekenhuis, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Martini Ziekenhuis, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 23 trials that are defined as “Not Applicable".

Martini Ziekenhuis has several departments that took part in Clinical trials: "Martini Ziekenhuis; Dept of Internal Medicine" - 4 trials